Liver neuroendocrine carcinoma

MONDO:0015072

An extremely rare, aggressive, high-grade and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the liver.

Also known as: HNEC, PHNEC, hepatic neuroendocrine carcinoma, liver neuroendocrine cancer, liver neuroendocrine carcinoma, neuroendocrine carcinoma of liver, primary hepatic neuroendocrine carcinoma, primary liver neuroendocrine carcinoma

2936 clinical trials for this condition and its sub-types, 3 tagged with Liver neuroendocrine carcinoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Carcinoma of liver and intrahepatic biliary tract (1461) ↑ Neuroendocrine carcinoma (744) ↑ Digestive system neuroendocrine neoplasm (167)

Sub-types of Liver neuroendocrine carcinoma

Ampulla of vater small cell neuroendocrine carcinoma 0 trials
Extrahepatic bile duct small cell adenocarcinoma 0 trials

Including sub-types (2936) Tagged with Liver neuroendocrine carcinoma (3)

Trials to join now! 2 Completed 1

New pill could ease carcinoid syndrome Flare-Ups

Symptom relief Completed

This Phase 2 trial tested paltusotine, an oral drug, in 36 adults with carcinoid syndrome. The study looked at safety and how the body processes the drug at different doses. Participants were randomly assigned to 40 mg or 80 mg daily, with dose adjustments allowed. The goal is to…

Phase 2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 11:02 UTC

Liver neuroendocrine carcinoma

Where it sits in the disease tree

New pill could ease carcinoid syndrome Flare-Ups